Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds B. Riley Securities Downgrades Novavax to Neutral, Lowers Price Target to $10

B. Riley Securities Downgrades Novavax to Neutral, Lowers Price Target to $10

B. Riley Securities analyst Mayank Mamtani downgrades Novavax (NASDAQ:NVAX) from Buy to Neutral and lowers the price target from $29 to $10.

March 1, 2023

1 minute read

B. Riley Securities analyst Mayank Mamtani downgrades Novavax (NASDAQ:NVAX) from Buy to Neutral and lowers the price target from $29 to $10.

Cronos Group Form 4 Filing Shows Director Jason Marc Adler Bought 291,400 Shares At An Average Price Of $2.87/Share

December 12, 5:25 PM

1. Name and Address of Reporting Person* ADLER JASON MARC (Last) (First) (Middle) 111 PETER

July 13, 2:52 PM

Stifel analyst Bert Subin reiterated a

July 14, 11:00 AM

Within the last quarter, Glaukos (NYSE:GKOS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

September 15, 2:00 PM

Over the past 3 months, 15 analysts have published their opinion on Constellation Brands (NYSE:STZ) stock. These analysts…